Ilex Medical Ltd (TLV:ILX)
Israel · Delayed Price · Currency is ILS · Price in ILA 4,866.00
-101.00 (-2.03%)
Aug 7, 2026, 1:44 PM IDT
Ilex Medical Financials Overview
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 906.15 | 930.83 | 920.37 | 916.25 | 863.28 | 1,061 |
Revenue Growth | -1.73% | 1.14% | 0.45% | 6.13% | -18.63% | 12.10% |
Gross Profit Gross Profit Growth | 205.61 | 211.88 | 216.31 | 226.9 | 282.91 | 379.38 |
Operating Income Operating Income Growth | 48.16 | 55.81 | 62.77 | 77.34 | 146.35 | 246.14 |
Net Income Net Income Growth | 51.36 | 55.56 | 38.98 | 50.89 | 102.12 | 197.48 |
Earnings Per Share EPS Growth | 4.60 | 4.97 | 3.48 | 4.55 | 9.05 | 17.50 |
EPS Growth | 50.92% | 42.52% | -23.34% | -49.80% | -48.27% | 55.66% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
ILEX Laboratory Instruments - Medical Equipment and Diagnostic Materials ILEX Laboratory Instruments - Medical Equipment and Diagnostic Materials Growth | 428.92 | 440.3 | 449.86 | 454.52 | 528.05 | 695.25 |
Medtechnica Medical Equipment Medtechnica Medical Equipment Growth | 474.11 | 487.96 | 468.25 | 459.46 | 332.56 | 336.71 |
Other Other Growth | 3.11 | 2.57 | 2.26 | 2.27 | 2.68 | 2.94 |
Total Total Growth | 906.15 | 930.83 | 920.37 | 916.25 | 863.28 | 1,061 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 216.7 | 235.11 | 236.88 | 217.11 | 225.7 | 284.75 |
Total Debt Total Debt Growth | 49.2 | 46.6 | 51.35 | 48.27 | 51.55 | 58.74 |
Net Cash (Debt) Net Cash Growth | 167.51 | 188.51 | 185.53 | 168.84 | 174.15 | 226.02 |
Net Cash Growth | -4.69% | 1.60% | 9.88% | -3.04% | -22.95% | 107.33% |
Net Cash Per Share Net Cash Per Share Growth | 15.00 | 16.85 | 16.58 | 15.09 | 15.44 | 20.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 83.56 | 72.87 | 81.63 | 80.43 | 69.74 | 270.68 |
Capital Expenditures CapEx Growth | -24.46 | -26.98 | -29.76 | -48.77 | -26.14 | -40.94 |
Free Cash Flow Free Cash Flow Growth | 59.1 | 45.89 | 51.87 | 31.66 | 43.6 | 229.73 |
Free Cash Flow Growth | 76.52% | -11.53% | 63.83% | -27.38% | -81.02% | 66.35% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 22.69% | 22.76% | 23.50% | 24.76% | 32.77% | 35.76% |
Operating Margin | 5.32% | 6.00% | 6.82% | 8.44% | 16.95% | 23.20% |
Pretax Margin | 7.64% | 7.96% | 6.69% | 8.08% | 16.57% | 24.07% |
Profit Margin | 5.67% | 5.97% | 4.23% | 5.55% | 11.83% | 18.61% |
FCF Margin | 6.52% | 4.93% | 5.64% | 3.46% | 5.05% | 21.65% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.986 | 1.986 | 1.220 | 1.365 | 1.917 | 5.319 |
Dividend Per Share Growth | 62.87% | 62.87% | -10.63% | -28.80% | -63.97% | 0% |
Dividend Yield | 3.97% | 3.08% | 1.72% | 2.50% | 2.21% | 3.74% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 8, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.88 | 13.43 | 21.61 | 13.04 | 10.58 | 9.29 |
P/FCF Ratio | 9.47 | 16.25 | 16.24 | 20.95 | 24.79 | 7.98 |
PS Ratio | 0.62 | 0.80 | 0.92 | 0.72 | 1.25 | 1.73 |